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Abstract
The sodium/calcium exchangers (NCX) use the extracellular sodium concentration to facilitate the extrusion of
calcium out of the cell. Alongside the plasma membrane Ca2+-ATPase (PMCA) and sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase (SERCA), as well as the sodium/potassium/calcium exchangers (NKCX, SLC24 family),
NCX allow recovery of intracellular calcium back to basal levels after cellular stimulation. When intracellular
sodium ion levels rise, for example, following depolarisation, these transporters can operate in the reverse
direction to allow calcium influx and sodium efflux, as an electrogenic mechanism. Structural modelling suggests
the presence of 9 TM segments, with a large intracellular loop between the fifth and sixth TM segments.
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This is a citation summary for SLC8 family of sodium/calcium exchangers in the Guide to Pharmacology
database (GtoPdb). It exists purely as an adjunct to the database to facilitate the recognition of citations to and
from the database by citation analyzers. Readers will almost certainly want to visit the relevant sections of the
database which are given here under database links.
GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a
reference work which is most usefully represented as an on-line database. As in any publication this work
should be appropriately cited, and the papers it cites should also be recognized. This document provides a
citation for the relevant parts of the database, and also provides a reference list for the research cited by those
parts.
Please note that the database version for the citations given in GtoPdb are to the most recent preceding version
in which the family or its subfamilies and targets were substantially changed. The links below are to the current
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Database links
SLC8 family of sodium/calcium exchangers
http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=180
    Transporters
            NCX1(Sodium/calcium exchanger 1)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=945
            NCX2(Sodium/calcium exchanger 2)
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            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=946
            NCX3(Sodium/calcium exchanger 3)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=947
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